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Keratin 16–Null Mice Develop Palmoplantar
Keratoderma, a Hallmark Feature of Pachyonychia
Congenita and Related Disorders
Juliane C. Lessard1,2 and Pierre A. Coulombe1,2,3
Keratin 16 (KRT16 in human, Krt16 in mouse), a type I intermediate filament protein, is constitutively expressed
in epithelial appendages and is induced in the epidermis upon wounding and other stressors. Mutations
altering the coding sequence of KRT16 cause pachyonychia congenita (PC), a rare autosomal dominant disorder
characterized by hypertrophic nail dystrophy, oral leukokeratosis, and palmoplantar keratoderma (PPK). PPK
associated with PC is extremely painful and compromises patient mobility, making it the most debilitating PC
symptom. In this study, we show that, although inherited in a recessive manner, the inactivation of Krt16 in mice
consistently causes oral lesions as well as PPK-like hyperkeratotic calluses on Krt16/ front and hind paws,
which severely compromise the animals’ ability to walk. Our findings call into question the view that PC-related
PPK arises exclusively as a gain-of-function on account of dominantly acting mutated keratins, and highlight the
key role of modifiers in the clinical heterogeneity of PC symptoms.
Journal of Investigative Dermatology (2012) 132, 1384–1391; doi:10.1038/jid.2012.6; published online 16 February 2012
INTRODUCTION
Keratin 16 (KRT16 in human, Krt16 in mouse), a type I
intermediate filament protein, is constitutively expressed in a
variety of epithelial appendages, including the tongue and
the hair follicle, and in glabrous skin (Moll et al., 1982;
Swensson et al., 1998; Bernot et al., 2002). Upon stressful
epithelial stimuli, such as wounding or chronic inflammation,
Krt16 and its binding partner Krt6 are selectively induced in
the suprabasal layers of the epidermis (Paladini et al., 1996).
Mutations in KRT16 are associated with the development of
pachyonychia congenita (PC), a rare autosomal dominant
disorder characterized by hypertrophic nail dystrophy,
palmoplantar keratoderma (PPK), and oral leukokeratosis
(McLean et al., 1995). PC symptoms are highly variable in
penetrance, age of onset, and severity, even between
individuals with the same mutation (Leachman et al., 2005;
Liao et al., 2007; Fu et al., 2011). In patients carrying KRT16
mutations, PPK is the most prominent symptom and may
sometimes appear as focal PPK (FPPK) with little or no nail
involvement (Shamsher et al., 1995; Leachman et al., 2005;
Smith et al., 2000, 2005; Liao et al., 2007). KRT16 mutation-
linked PPK is typically non-epidermolytic (McLean et al.,
1995; Shamsher et al., 1995; Liao et al., 2007), although
blistering underneath and around PPK calluses has been
linked to palmoplantar pain in PC patients (Dahl et al., 1995).
Previous mouse models harboring both dominant and
recessive mutations in Krt6 and Krt75 recapitulate several
PC-like symptoms (Wong et al., 2000, 2005; Wojcik et al.,
2001; Chen et al., 2008), but have failed to phenocopy PPK,
which is considered to be the most debilitating PC symptom
as it is extremely painful and significantly impacts patient
mobility and quality of life (Dahl et al., 1995; Leachman
et al., 2005). In this study, we show that adult mice lacking
Krt16 develop hyperkeratotic calluses on their front and hind
paws that are strikingly similar to human PPK and signifi-
cantly compromise the animals’ ability to walk.
RESULTS
Failure to thrive and increased postnatal mortality in Krt16/
mice
Krt16/ mice were born alive at approximately Mendelian
ratios and were initially visually indistinguishable from
wild-type (WT) and Krt16þ / littermates (Supplementary
Figure S1A online). However, 34% of Krt16/ mice died
within the first 24 hours after birth, as opposed to 6% of WT
and 11% of Krt16þ / mice (Figure 1a). Toluidine Blue dye
exclusion assays performed on newborn pups ruled out any
gross early postnatal skin barrier defects in Krt16/
(Supplementary Figure S1B online). Newborn Krt16/ mice
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weighed less than their littermates (Supplementary Figure
S1C online) and subsequently continued to lag behind their
littermates in size and in weight (Figure 1b and c). Such
phenotypic changes coincided with the persistence of a
markedly higher level of postnatal mortality, and over 60% of
Krt16/ mice died before weaning age. The Krt16/ mice
that did survive continued to grow and gained weight, but
remained smaller and lighter than their littermate controls
(data not shown).
Krt16 is essential for the structural integrity of the dorsal tongue
epithelium
Mice lacking the Krt16 binding partners, Krt6a and Krt6b,
exhibit a more severe albeit similar growth retardation and
early postnatal lethality phenotype (Wong et al., 2000;
Wojcik et al., 2001). In Krt6a/b/ mice, the formation of
large hyperplastic lesions on the dorsal posterior tongue (akin
to oral leukokeratosis, a PC symptom) is thought to occlude
the laryngeal space, impair feeding, and lead to early death
due to starvation. Such laryngeal obstruction, although
extremely rare, has been reported in pediatric PC patients
carrying KRT6a mutations (Smith et al., 2005; Haber and
Drummond, 2011), and infants suffering from oral leukoker-
atosis often have trouble breastfeeding (Leachman et al.,
2005).
When we examined the tongues of Krt16/ mice at
different ages, we also detected the presence of hyperplastic
lesions, which are fully penetrant and become macroscopi-
cally and microscopically visible by P3 (Figure 1c and d).
These lesions were confined to the dorsal midline area of the
posterior tongue and were smaller than those observed in
Krt6a/b/ mice (Wong et al., 2000). Surviving Krt16/ mice
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Figure 1. Failure to thrive, high postnatal mortality, and posterior tongue lesions in Krt16/ mice. (a) High postnatal mortality in Krt16/ mice.
Thirty-four percent of Krt16/ mice die within 24 hours after birth; only a third survive past weaning. (b) Krt16/ mice weigh significantly less than
control littermates. Error bars denote standard error of the mean. (c) P17 Krt16/ mice are smaller than littermates and a white-yellow plaque covers the
posterior dorsal area of their tongues (arrowhead). (d) Hematoxylin and eosin–stained sections of posterior tongues at P0 and P7. Krt16/mice show no obvious
defects at birth. By P7, the architecture of filiform papillae (fp) is markedly disrupted, and massive hyperkeratosis leads to macroscopically visible plaques.
Note the paucity of cell lysis in the suprabasal layer. Dotted line indicates the epithelial/muscle junction. Bar¼ 50 mm.
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no longer had visible lesions, but the tongue architecture
remained severely compromised, showing a thickened
epithelium and loss of the characteristic filiform papillae
morphology (Supplementary Figure S2A online). Although no
epithelial fragility was detectable by routine histology in P0
Krt16/ tongues (Figure 1d), transmission electron micro-
scopy revealed early stages of cell lysis in a subset of posterior
filiform papillae (Supplementary Figure S2B online). Interest-
ingly, Krt17 protein, and to a lesser extent Krt17 mRNA,
levels were significantly reduced in the tongue epithelium of
Krt16/ mice (Figure 2a and b), and immunofluorescence
staining for Krt17 was consistently absent from the anterior
column of Krt16/ filiform papillae, but not the fungiform
papillae (Figure 2a). The expression of Krt5, Krt6 and Krt10
was normal in Krt16/ filiform papillae (Figure 2a and b),
suggesting that the loss of Krt17 was not due to an overall
change in the differentiation program in the anterior column
of filiform papillae. The constitutive and inducible expression
of Krt17 in other tissues, including skin, was not affected
(Figure 2a and 4d). Our findings thus extend the notion that
Krt6- and Krt16-containing filaments are essential for the
maintenance of dorsal tongue epithelial integrity. Loss of
Krt16 and concomitant reduction of Krt17 levels deplete
most, but not all, of Krt6’s primary binding partners in the
tongue epithelium, leading to increased cell fragility and
hyperplastic lesion formation, starvation, and a higher chance
of postnatal death in Krt16/ mice. Residual levels of Krt17
present in Krt16/ tongue epithelium may explain the
smaller lesions and lower number of early deaths in Krt16/
mice as compared with Krt6a/b/ mice (Wong et al., 2000;
Wojcik et al., 2001). Despite their less severe nature, we
cannot rule out the possibility that oral lesions in Krt16/
mice are painful and thus impact feeding behavior.
Adult Krt16/ develop PPK
Starting at 4–6 weeks of age, surviving Krt16/ mice
developed prominent, hyperkeratotic calluses on the glab-
rous parts of both front and hind paws (Figure 3a–c). The
boundaries of these calluses did not directly correlate with
the loss of endogenous Krt16, which is expressed in a patchy
manner throughout paw pad epithelia, including the nail
hyponychium, as shown by whole-mount X-gal (5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside) staining (Figure
3a). Instead, consistent with focal PPK (FPPK) in human PC
patients, calluses in Krt16/ mice were restricted to areas
subject to physical pressure, i.e., the heel and the wrist
(Figure 3a). Occasionally, we observed generalized hyper-
keratosis on the front paw pads as early as at 3 weeks of age
(Supplementary Figure S3A online), and focal hyperkeratosis
near the base of the tail. Importantly, nail morphology was
not affected in Krt16/ mice (Supplementary Figure S3B
online).
The age of onset for callus formation on both front and
hind paws was variable, and calluses differed in severity
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between animals (Figure 3a shows two representative
examples of callus severity in Krt16/). In all 36% of
Krt16/ mice showed no alteration of their hind paw pads at
all. Hind paw calluses also consistently formed after front
paw pad calluses were already established. Visual changes in
Krt16/ front paw pads correlated with an expanded
epidermal compartment (Figure 3b) that correlated with a
2-fold increase in proliferation (Figure 4c) in the absence of
apoptotic cell death (Supplementary Figure S3C online).
Areas adjacent to the callus showed a thickened epithelium,
but no significant increase in proliferation (Figure 3b and 4c).
Paw pad epithelia in younger mice with no obvious signs of
callus formation were indistinguishable from controls (data
not shown). As PPK in humans greatly impairs mobility, we
asked whether callus formation in Krt16/ mice has a
negative impact on the animals’ activity level in a
behavioral assay. We found that adult Krt16/ mice are
significantly less active than control animals and spend more
time resting than walking (Figure 4a, Supplementary Figure
S3D online). Several anomalies, including the patchy
expression of Krt17 (which is absent from control mouse
paw pad epidermis) and focal toluidine blue dye penetration
(Figure 4b and d), suggested a disruption of the outside-in
epidermal barrier in Krt16/ front paw calluses, which may
Krt16 +/– X-galKrt16 –/–Krt16 –/–Control
ControlKrt16 –/–Control
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sc epi sc Krt16 –/–
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b
Figure 3. Krt16/ mice develop palmoplantar keratoderma. (a) Adult Krt16/ mice develop PPK-like lesions in their front and hind paws.
Callus formation is common in areas of high physical impact (arrowheads), despite the global Krt16 expression pattern in glabrous skin (see the X-gal
(5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) stain). Note the presence of focal hyperpigmentation in front paw calluses. (b) Hematoxylin and
eosin-stained cross-sections of front paws, showing expansion of the epidermis (epi) and massive hyperkeratosis in Krt16/ mice. Occasionally, focal
suprabasal lysis is observed in Krt16/ calluses (arrowheads). Bar¼100 mm (calluses), 50 mm (insets). (c) Hyperkeratosis without lysis in Krt16/ hind paw
epidermis. Note the change in shape and arrangement of suprabasal nuclei. Bar¼ 50 mm. b, basal layer; sb, suprabasal layer; sc, stratum corneum.
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lead to secondary infections as implied by the presence of
prominent hyper-pigmentation in those areas (Figure 3a).
Krt17 expression is induced in response to barrier breach
(McGowan and Coulombe, 1998; DePianto et al., 2010), and
a mutation in the barrier protein filaggrin has been shown to
intensify PC-related symptoms in a human patient with a
coincident Krt16 mutation (Liao et al., 2007; Gruber et al.,
2009). Filaggrin expression is normal in Krt16/ paw pad
epithelia, as reported for PC plantar lesions (Wollina et al.,
1991), but is reduced in established front paw calluses (Figure
4d), confirming that Krt16/ glabrous skin, although initially
intact, is eventually unable to fend off the continuous
physical pressure generated by walking and/or cleaning
behavior, resulting in hyperproliferation and a focal loss of
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barrier protection. In humans, PPK is very painful. The cause
of the pain is unknown, but clinical observations have noted
the formation of blisters underneath or adjacent to calluses
(Dahl et al., 1995), as well as secondary infections following
fissuring of the hyperkeratotic tissue (Leachman et al., 2005).
Alternatively, it is possible that PPK calluses exert an
increased pressure on nerve endings in plantar skin,
especially while walking. Although an objective assessment
of the level and type of pain or its source in Krt16/ mice is
beyond the scope of this study, we hypothesize that Krt16/
mice experience substantial discomfort as a direct result of
palmoplantar lesions and thus exhibit a significant decrease
in their overall mobility.
DISCUSSION
Here, we show that the loss of Krt16 function in mice causes
the development of prominent calluses on the plantar side of
front and hind paws, which significantly compromise
mobility and eventually lead to overt loss of barrier proper-
ties. Although the molecular mechanism of PPK pathogenesis
in PC is still unclear, this symptom is currently thought to
develop as a consequence of intermediate filament network
disruption by dominantly-acting mutations in relevant kera-
tins (Fu et al., 2011). To our surprise, deletion of Krt16
produced spontaneously arising PPK-like lesions in mice,
suggesting that PPK pathogenesis in PC is more complex than
previously appreciated and may represent, at least in part,
a loss of function phenotype. Almost all human PC patients
harboring KRT16 mutations report PPK (Leachman et al.,
2005; Liao et al., 2007; Fu et al., 2011). However, many
mutations in KRT16 only elicit milder overall PC phenotypes,
often diagnosed as FPPK because of the limited and at times
absent nail involvement (Shamsher et al., 1995; Smith et al.,
2000, 2005; Liao et al., 2007). In particular, this is seen with
small deletions in KRT16, which are thought to cause
exclusion of the mutant form of KRT16 from filament
assembly (Smith et al., 2000; Wilson et al., 2009; Cao
et al., 2011). These findings together with our data suggest
that both the dominant-negative disruption of intermediate
filaments as well as the exclusion of keratins from the
network can contribute to PPK pathogenesis. Nail dystrophy,
on the other hand, was not observed in Krt16/ mice, and
may depend more heavily on the dominant-negative inter-
ference of keratin filaments. Accordingly, the deletion of
individual or even multiple keratins leads to no or very minor
nail defects in mice (Wong et al., 2000, 2005; Wojcik et al.,
2001; this study), whereas a dominant mutation in Krt75
elicits the characteristic nail overgrowth in mouse (Chen
et al., 2008). In humans, where all known PC-causative
keratin mutations are dominant, nail involvement is highly
penetrant. These observations in humans, mouse models,
and now our findings in Krt16/ mice showcase how a
combination of loss- and gain-of-function phenotypes can
contribute to the complex overall clinical presentation of PC.
Furthermore, our data substantiate the hypothesis that FPPK
and PC can share a common pathogenesis (Wilson et al.,
2009; Bowden, 2010), as Krt16/ mice developed FPPK
along with oral lesions, another PC-like symptom. We also
noticed differences in disease onset, phenotype severity, and
change in barrier permeability in Krt16/ mice, supporting
the idea of keratin, non-keratin, and/or environmental
modifiers in PPK pathogenesis (Smith et al., 2000). It will
be interesting to examine whether the mechanism(s) by
which loss of Krt16 results in the development of PPK
overlap(s) with the pathogenesis of other keratoderma,
e.g., striate PPK (Desmoplakin) or diffuse PPK (KRT1,
Desmoglein).
We only observed occasional and locally restricted areas
of cell lysis in established Krt16/ front paw calluses (Figure
3b, arrowhead and inset), but never in hind paw calluses or
uninvolved skin, despite the global expression pattern of
Krt16 in glabrous tissue. Expression of other structurally
important keratins in the suprabasal layer, such as Krt1 and
Krt10, was also generally intact (Figure 4d) and likely
contributes to the maintenance of cellular integrity in the
absence of Krt16. Thus, we speculate that Krt16 has an
additional function in glabrous skin, separate from its role of
structural support. Several studies have already implicated
Krt16 and other type 1 keratins, such as Krt10 and Krt17, as
significant players in epidermal homeostasis (Takahashi et al.,
1994; Paladini et al., 1996; Reichelt and Magin, 2002; Kim
et al., 2006; DePianto et al., 2010). A key feature of Krt16
expression in the skin is its selective induction following
injury, UV exposure, or in chronic disease states (e.g.,
psoriasis; Leigh et al., 1995; Paladini et al., 1996; Del Bino
et al., 2004). Glabrous skin is a specialized tissue designed to
withstand and adapt to significant mechanical trauma
(Bowden et al., 1987; Swensson et al., 1998). It will be
worth investigating the function of constitutive Krt16 expres-
sion in this unique environment, and whether the underlying
mechanism bears any relationship to the role(s) fulfilled by
Krt16 when induced by injury and other relevant stressors.
MATERIALS AND METHODS
Generation of Krt16/ mice
C57 Bl/6 ES cells in which the Krt16 coding sequence has been
replaced with a lacZ-loxP-NeoR-loxP cassette were created by
Velocigene using funds provided by the trans-NIH KOMP (Knock-
Out Mouse Project), and obtained from the KOMP repository
(supported by the NCRR-NIH). ES cells were injected into C57 Bl/
6cBrd/cBrd albino blastocysts (distributed by the NCI, Frederick, MD).
A high coat color male chimera was bred to C57 Bl/6cBrd/cBrd albino
females and 100% germline transmission was observed. Krt16þ / F1
offspring were born at the expected 50:50 ratio and inter-crossed to
generate Krt16/ mice. All experiments involving mice were
reviewed and approved by the Johns Hopkins Institutional Animal
Care and Use Committee. Mouse lines were maintained under
specific pathogen-free conditions, and fed chow and water ad
libitum. All experiments were performed using littermate controls
(wild-type or Krt16þ /).
Histopathology and immunofluorescence
Whole tongues and paws were fixed overnight in Bouin’s (Sigma,
St Louis, MO) or 4% para-formaldehyde/phosphate-buffered saline
(PBS). Tissue was then either rinsed and embedded in Sakura Tissue-
Tek OCT. (VWR, Radnor, PA), or dehydrated and processed for
www.jidonline.org 1389
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routine paraffin embedding. Sections were cut at 5 mm and stained
with hematoxylin/eosin according to standard protocols. For immu-
nofluorescence, frozen sections or re-hydrated paraffin-embedded
sections were washed in PBS, blocked in 5% normal goat serum,
0.1% Triton-X100 for 1 hour at room temperature, incubated in
primary antibody solution (2.5% normal goat serum, 0.1% Triton-
X100) for 1 hour at room temperature, washed in PBS, incubated in
secondary antibody (2.5% NGS) for 1 hour, counterstained with
DAPI, mounted, and imaged using an inverted Zeiss (Thornwood,
NY) fluorescence microscope with ApoTome attachment. Antibodies
used were directed against Krt17 (1:1,000; McGowan and Cou-
lombe, 1998), Krt6 (1:250; McGowan and Coulombe, 1998), Krt10
(1:500; Covance, Princeton, NJ), filaggrin (1:500; Covance), Ki67
(Sp6 clone, 1:200; ThermoFisher, Pittsburgh, PA), and Alexa-
Fluor488 (1:1,000; Invitrogen, Carlsbad, CA). TUNEL staining was
performed as described (McGowan et al., 2002).
Whole-mount X-gal and barrier function assays
Whole paws were fixed for 1 hour in 4% paraformaldehyde/PBS at
4 1C, washed in PBS, and permeabilized via 3 15-minute washes in
PBS containing 2mM MgCl2, 0.01% sodium deoxycholate, and
0.02% NP-40. The tissue was then transferred to scintillation vials
containing a 1-mgml1 X-gal solution (30mM K4Fe(CN)6, 30mM
K3Fe(CN)6, 2mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-
40, PBS) for 30minutes at 30 1C. Samples were photographed
immediately. Toluidine Blue dye staining, to assess outside-in barrier
function, was carried out on newborn pups and adult paws as
described (Hardman et al., 1998).
Behavioral assays to assess mobility
Individual mice were allowed to acclimate for 30minutes and then
placed into a rectangular plexiglas chamber with a stainless-steel
floor. To eliminate outside positional cues, the chamber was
uniformly illuminated and its sides masked with a cardboard.
Mobility was monitored over a time frame of 30minutes for infrared
beam-breaking activity and the data were recorded using the
Optimax software (Columbus Instruments, Columbus, OH). Results
represent the average of three separate experiments.
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